Gapping down
In reaction to disappointing earnings/guidance: ERB -1.4%.
Select EU related names showing weakness: SAN -6%, DB -5.9%, ING -4.8%, NOK -4.6%, SNY -4.2%, E -3.9%, ALU -3.7%, ORAN -3.5%, UN -3.3%, SAP -2%
Select China related names trading lower: ZNH -7%, JMEI -6.3%, CMCM -5.1%, TEDU -4.8%, JKS -3.3%, JD -2.6%, DANG -2.1%, YUM -2%
Select oil/gas related names showing early weakness: TOT -4.3%, SDRL -3.8%, STO -3.6%, AEG -3.5%
Other news: NBG -21.9% (cont uncertainty in Greece), AGO -12.9% (NYTimes DealBook reporting Puerto Rico cannot pay $72 bln in debt), CBLI -9.2% (cont volatility), BTU -6.1% (still checking), FIT -4.1% (volatilty post IPO), RDHL -3.3% (initiates a Phase I/II clinical study in the US, evaluating ABC294640 in patients with refractory/relapsed diffuse large B-cell lymphoma), PM-2.2% (says its PT HM Sampoerna subsidiary will explore options to comply with the Indonesian Stock Exchange's mandatory requirement of a minimum threshold for public shareholding), CLDX -1.9% (independent Data Safety and Monitoring Board recommended continuation of the Phase 3 ACT IV study of RINTEGA), TWTR -1.8% (VP of Corporate Development and Strategy Rishi Garg tweets he is leaving the company)
Analyst comments: MBI -6.7% (downgraded to Neutral at BTIG Research), YOKU -5.3% (downgraded to Underperform from Neutral at Mizuho), MKTX -2.7% (downgraded to Underperform from Neutral at Macquarie), M -2.6% (downgraded to Sell from Buy at Deutsche Bank), FFIV -2.4% (downgraded to Neutral from Overweight at Piper Jaffray), QCOM -1.9% (downgraded to Sell from Hold at Drexel Hamilton), XOOM -1.8% (downgraded to Neutral from Positive at Susquehanna), JPM -1.7% (downgraded to Perform at Oppenheimer ), STI -1.7% (downgraded to Perform at Oppenheimer ), AA -1.6% (target lowered to $16 at Morgan Stanley), FBP -1.2% (downgraded to Neutral from Buy at Guggenheim), KYTH -0.8% (downgraded to Market Perform from Outperform at Leerink)
In reaction to disappointing earnings/guidance: ERB -1.4%.
Select EU related names showing weakness: SAN -6%, DB -5.9%, ING -4.8%, NOK -4.6%, SNY -4.2%, E -3.9%, ALU -3.7%, ORAN -3.5%, UN -3.3%, SAP -2%
Select China related names trading lower: ZNH -7%, JMEI -6.3%, CMCM -5.1%, TEDU -4.8%, JKS -3.3%, JD -2.6%, DANG -2.1%, YUM -2%
Select oil/gas related names showing early weakness: TOT -4.3%, SDRL -3.8%, STO -3.6%, AEG -3.5%
Other news: NBG -21.9% (cont uncertainty in Greece), AGO -12.9% (NYTimes DealBook reporting Puerto Rico cannot pay $72 bln in debt), CBLI -9.2% (cont volatility), BTU -6.1% (still checking), FIT -4.1% (volatilty post IPO), RDHL -3.3% (initiates a Phase I/II clinical study in the US, evaluating ABC294640 in patients with refractory/relapsed diffuse large B-cell lymphoma), PM-2.2% (says its PT HM Sampoerna subsidiary will explore options to comply with the Indonesian Stock Exchange's mandatory requirement of a minimum threshold for public shareholding), CLDX -1.9% (independent Data Safety and Monitoring Board recommended continuation of the Phase 3 ACT IV study of RINTEGA), TWTR -1.8% (VP of Corporate Development and Strategy Rishi Garg tweets he is leaving the company)
Analyst comments: MBI -6.7% (downgraded to Neutral at BTIG Research), YOKU -5.3% (downgraded to Underperform from Neutral at Mizuho), MKTX -2.7% (downgraded to Underperform from Neutral at Macquarie), M -2.6% (downgraded to Sell from Buy at Deutsche Bank), FFIV -2.4% (downgraded to Neutral from Overweight at Piper Jaffray), QCOM -1.9% (downgraded to Sell from Hold at Drexel Hamilton), XOOM -1.8% (downgraded to Neutral from Positive at Susquehanna), JPM -1.7% (downgraded to Perform at Oppenheimer ), STI -1.7% (downgraded to Perform at Oppenheimer ), AA -1.6% (target lowered to $16 at Morgan Stanley), FBP -1.2% (downgraded to Neutral from Buy at Guggenheim), KYTH -0.8% (downgraded to Market Perform from Outperform at Leerink)